Public Affairs & Government Relations

The Netherlands: Europe’s Most Attractive Life Sciences Hotspot, or the Next Big Troublemaker?

The Netherlands certainly has a lot going for it when it comes to attracting the world’s leading biopharmaceutical companies: World-class research institutes, a well-respected healthcare system and not least of all the new home of the European Medicines Agency.

FTI Consulting Brussels and IvCB explore whether there is another side to the story. Read more here- A New Healthcare Hotspot?

Related Articles

January 14, 2022

FTI Consulting News Bytes – 14th January 2022

Welcome to FTI Consulting News Bytes – a roundup of top tech stories of the week from FTI Consulting’s TMT (Telecom,...

January 13, 2022

FTI Consulting Public Affairs Snapshot: To CBDC or not to CBDC?

The Mesopotamian shekel is often cited as the first form of money, initially representing a specific weight of barley, a...

January 13, 2022

ESG+ Newsletter – 13th January 2022

Your weekly updates on ESG and more Greetings from 2022! Our first ESG+ Newsletter of the year starts off with a review ...